If sulfonylurea poisoning is suspected or confirmed, the patient is at risk for recurrent hypoglycemia and should be admitted for monitoring and consideration of ongoing octreotide therapy
1 2 American Academy of Dermatology (February 2013), "Five Things Physicians and Patients Should Question", Choosing Wisely: an initiative of the ABIM Foundation , American Academy of Dermatology, archived from the original on 1 December 2013, retrieved 5 December 2013, which cites: al
They work through different mechanisms that complement each other, which is why most recovery-peptide clinics prescribe them as a stack rather than asking patients to choose
Why do some people not respond to semaglutide in the UK
Qi X, Zhang Y, Guo H, Hai Y, Luo Y, Yue T